Maynard Um
-
-
-
-
-
-
-
Heartbeam Inc. (BEAT) PT Lowered to $5 at Benchmark After Q1 Results
-
-
-
-
-
-
-
HeartBeam, Inc (BEAT) Misses Q4 EPS by 46c
-
-
-
-
-
-
-
HeartBeam receives FDA rejection, pursues multiple paths for approval
-
-
-
-
-
-
-
HeartBeam, Inc (BEAT) Misses Q1 EPS by 2c
-
-
-
-
-
-
-
HeartBeam, Inc (BEAT) Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
-
-
-
-
-
-
-
Benchmark Reiterates Speculative Buy Rating on Heartbeam Inc. (BEAT)
-
419,120 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

